Impact of microbial Aetiology on mortality in severe community-acquired pneumonia

Jessica Quah1, Boran Jiang2, Poh Choo Tan3

  • 1Department of Respiratory and Critical Care Medicine, Changi General Hospital, SingHealth, 2 Simei Street 3, Postal Code, Singapore, 529889, Singapore. Jessica_Quah@cgh.com.sg.

BMC Infectious Diseases
|September 6, 2018
PubMed
Abstract

Insights

Mixed viral-bacterial infections in severe community-acquired pneumonia (CAP) significantly increase mortality risk. Identifying these co-infections is crucial for patient outcomes in severe CAP cases.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Respiratory Medicine

Background:

  • Severe community-acquired pneumonia (CAP) etiology and mortality impact remain unclear.
  • Previous studies show conflicting data on viral, bacterial, and mixed infections in CAP.
  • Molecular diagnostics are increasingly used to identify pathogens in severe CAP.

Purpose of the Study:

  • To determine the association between microbial etiologies and hospital mortality in severe CAP.
  • To investigate the role of respiratory viruses, particularly in mixed viral-bacterial co-infections.
  • To utilize molecular testing for comprehensive pathogen identification.

Main Methods:

  • Retrospective cohort study conducted in a tertiary hospital intensive care unit in Singapore.
  • Inclusion criteria: patients diagnosed with severe community-acquired pneumonia.
  • Data collected from January 2014 to July 2015, incorporating molecular testing.

Main Results:

  • Microbial pathogens identified in 71.8% of 117 severe CAP patients.
  • Mixed viral-bacterial co-infections found in 15.4% of patients.
  • Mixed viral-bacterial co-infections showed a significantly increased adjusted odds ratio of 13.99 for hospital mortality.

Conclusions:

  • Respiratory viruses are frequently detected in severe CAP.
  • Mixed viral-bacterial co-infections are associated with a substantially higher risk of hospital mortality.
  • Early identification of co-infections is vital for managing severe CAP.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
631
What are Populations and Communities?00:30

What are Populations and Communities?

Overview
37.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
900
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.0K
Impact of Groups on Groups01:19

Impact of Groups on Groups

Social psychologists analyze how groups influence one another, shaping social structures and interactions through both cooperation and competition. These dynamics manifest in various ways, ranging from economic partnerships to intergroup conflicts that shape societal structures and perceptions.Cooperation and Competition in Intergroup RelationsIntergroup relationships vary across contexts, sometimes fostering cooperation and mutual benefit while at other times leading to conflict and...
250
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
822